logo
  

EARNINGS SUMMARY: Details of Rigel Pharmaceuticals Inc. Q2 Earnings Report

Below are the earnings highlights for Rigel Pharmaceuticals Inc. (RIGL):

-Earnings: -$13.82 million in Q2 vs. -$17.58 million in the same period last year.
-EPS: -$0.08 in Q2 vs. -$0.10 in the same period last year.
-Analysts projected -$0.11 per share
-Revenue: $26.27 million in Q2 vs. $16.02 million in the same period last year.

For comments and feedback contact: editorial@rttnews.com

RELATED NEWS
Follow RTT